Updates
Study Finds Harmful Flame Retardants in 99% of Cars Analyzed
A recent CPCB study found that 99% of the vehicles tested contain the flame retardant TCIPP. Along with this, two other carcinogenic chemicals, TDCIPP and TCEP, were identified, posing significant health risks. Explore the full report and its potential impact on public health.
Emerging XEC Covid-19 Variant: Symptoms and Global Spread Explained
The XEC strain, a hybrid of KS.1.1 and KP.3.3, has recently emerged in 15 countries. Discover its symptoms and how it compares to other Covid-19 variants, as well as its rapid spread since detection in Germany.
Understanding Endometriosis: Diagnosis Rates and Impact on Daily Life
Discover the hidden struggles of endometriosis. This study shows that only 6.4% of U.S. women of reproductive age are diagnosed, while more than 67% endure debilitating pain that significantly disrupts their work and daily lives.
India Launches Urgent Relief Mission 'Sadbhav' for Typhoon-Affected Neighbors
India's 'Sadbhav' mission delivers quick relief supplies to Myanmar, Laos, and Vietnam, assisting in recovery efforts following the devastating effects of Typhoon Yagi. The initiative highlights regional solidarity amid natural disasters.
Tackling the Antibiotic Resistance Crisis in South Asia: A Call to Action
A new report forecasts that antibiotic resistance could lead to 11.8 million deaths in South Asia by 2050.Join the fight against antimicrobial resistance in India, Pakistan, and Bangladesh to protect public health and save lives.
Revolutionary Apple Watch Feature: Detect Sleep Apnea with Breathing Disturbances
Apple's new sleep apnea detection feature leverages metrics related to "breathing disturbances" to identify potential signs of the condition. By measuring wrist movements with its accelerometer, the Apple Watch identifies potential sleep apnea signs, validated through clinical studies for accuracy.
DCGI Suspends Approval of PresVu: Entod Pharmaceuticals Plans Legal Challenge
The DCGI has halted approval for PresVu, a drug by Entod Pharmaceuticals aimed at treating presbyopia. The company plans to challenge this suspension, citing lack of specific violations in the decision.
China's Drug Regulator Approves Mpox Vaccine for Clinical Trials
China’s drug regulator has approved the first mpox vaccine for clinical trials. Developed by Sinopharm, this experimental vaccine aims to combat mpox infections, marking a significant step in the country’s efforts to prevent the disease.
Fortis Healthcare Seeks Approval for Major Stake in Agilus
Fortis Healthcare has applied to the Competition Commission of India (CCI) for approval to increase its shareholding in diagnostics arm Agilus from 57.68% to 89.2%. The acquisition, worth ₹1,780 crore, aims to strengthen its diagnostics services.
Health Ministry Calls for Integration of Digital Health Portals
Union Health Secretary Apurva Chandra emphasizes the need to integrate the Health Management Information System (HMIS) portal with other ministry portals for timely data uploads and improved analysis in a meeting on healthcare infrastructure.
Mpox Case Confirmed in Traveler from Affected Country
The Union Health Ministry confirmed a case of Mpox in a man who recently returned from a country where the virus is being transmitted. The patient is isolated, and public health measures are in place to ensure containment.
India Confirms First Mpox Case, Not Part of Current Public Health Emergency
India has confirmed its first Mpox virus case, identified as a travel-related infection. The Union Health Ministry clarified that this case is isolated and not connected to the ongoing global public health emergency declared by the WHO.
